1999
DOI: 10.1038/sj.onc.1202928
|View full text |Cite
|
Sign up to set email alerts
|

Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells

Abstract: Ewing's sarcomas express chimeric transcription factors resulting from a fusion of the amino terminus of the EWS gene to the carboxyl terminus of one of ®ve ETS proteins. While the majority of tumors express EWS/ FLI1 fusions, some Ewing's tumors contain variant chimeras such as EWS/ETV1 that have divergent ETS DNA-binding domains. In spite of their structural dierences, both EWS/ETS fusions up regulate EAT-2, a previously described EWS/FLI1 target gene. In contrast to EWS/FLI1, NIH3T3 cells expressing EWS/ ET… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
79
0
1

Year Published

2000
2000
2016
2016

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 95 publications
(84 citation statements)
references
References 43 publications
3
79
0
1
Order By: Relevance
“…Although soft agar assays are often used as a measure for malignant transformation, the results do not necessarily correspond with the ability of the transfected cells to form tumors in vivo. In Ewing sarcomas, for example, several chimeric transcription factors such as EWS/FLI1 and EWS/ETV1 are thought to modulate aberrant gene expression leading to tumorigenesis (Thompson et al, 1999). Although both fusion products were able to confer a common tumorigenic phenotype onto NIH3T3 cells as measured by tumor formation in SCID mice, only one of them (EWS/FLI1) was able to form colonies in soft agar.…”
Section: Discussionmentioning
confidence: 99%
“…Although soft agar assays are often used as a measure for malignant transformation, the results do not necessarily correspond with the ability of the transfected cells to form tumors in vivo. In Ewing sarcomas, for example, several chimeric transcription factors such as EWS/FLI1 and EWS/ETV1 are thought to modulate aberrant gene expression leading to tumorigenesis (Thompson et al, 1999). Although both fusion products were able to confer a common tumorigenic phenotype onto NIH3T3 cells as measured by tumor formation in SCID mice, only one of them (EWS/FLI1) was able to form colonies in soft agar.…”
Section: Discussionmentioning
confidence: 99%
“…1,2 During the past decades, EWSR1 has been identified as a translocation partner for many transcription factors including FLI-1, ATF-1, NR4A3, and CHOP in diverse tumors. [3][4][5][6][7] Recently, an increasing number of studies have focused on the characterization of EWSR1 itself. EWSR1 is ubiquitously expressed in most human cell types, except for cardiac muscle cells and melanocytes.…”
Section: Introductionmentioning
confidence: 99%
“…Most mutations or deletions in the DBD result in almost complete loss of transforming potential (9,10). More recently, however, alternative in vivo-based tumor assays have been used to assay the oncogenic activity of EWS/ETS fusions proteins (11)(12)(13). In some of these experiments, it has become apparent that although often in agreement, these two different transformation assays do not always concur (13,14).…”
mentioning
confidence: 99%
“…More recently, however, alternative in vivo-based tumor assays have been used to assay the oncogenic activity of EWS/ETS fusions proteins (11)(12)(13). In some of these experiments, it has become apparent that although often in agreement, these two different transformation assays do not always concur (13,14). Because the ets DBD is one of two necessary FLI1 domains to promote anchorageindependent growth (10, 11), we investigated whether EWS/ FLI1 is dependent on this domain for the acceleration of tumor formation in SCID mice as well.…”
mentioning
confidence: 99%